Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yantai Dongsheng Biotechnology is a Chinese life science company that specializes in the development and manufacture of molecular biology reagents. Founded in 2005, the company provides a broad portfolio of products including PCR and qPCR master mixes, high-fidelity DNA polymerases, nucleic acid purification kits, and DNA ladders. These products are essential tools for genomic research, clinical diagnostics, and agricultural biotechnology applications. Dongsheng Biotech operates ISO 9001 and ISO 13485 certified facilities to ensure high-quality standards for its global customer base. The company is a significant supplier in the Chinese domestic market and exports its reagents to over 50 countries worldwide. Its mission is to provide cost-effective and reliable molecular biology solutions to the scientific community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yantai Dongsheng Biotechnology.